News - Page 6 of 9 - Cyclotek

Neuroinflammation as a Mechanism, Biomarker, and Therapeutic Target in Degenerative Brain Disorders

Posted on: 15 October 2017Research

Immune-responsive cells of the brain – namely microglia and astrocytes – activate in resp
read More
Advancing Molecular Imaging in NSW

Posted on: 19 September 2017Company

Media Release 19 September 2017 Cyclotek, Cyclopharm, PETTECH Solutions and Macquarie Univers
read More
Cyclotek improving diagnostic accuracy in Prostate Cancer

Posted on: 06 August 2017Company

Cyclotek, GE Healthcare and Macquarie University take-on prostate cancer
read More
ASAN Medical Centre and Duchembio, Korea, licence DAT PET tracer for Parkinson’s to Cyclotek

Posted on: 05 July 2017Research

ASAN Medical Center and Duchembio Co. Ltd. announce Strategic Partnership with Cyclotek for E
read More
Cyclotek appoints new Director

Posted on: 10 June 2017Company

Doug Cubbin appointed to the Cyclotek board
read More
Non-inferiority study of DCFPyL and Ga-68 prostate tracer published

Posted on: 08 January 2017Uncategorized

Our data suggest that 18F-DCFPyL is non-inferior to 68Ga-PSMA-HBED-CC
read More

© 2025 Cyclotek. All rights reserved

[contact-form-7 id=”714″ title=”Update Form”]